Agree To Buy Regeneron Pharmaceuticals At $210, Earn 7.1% Using Options
June 27, 2016 at 11:42 AM EDT
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (REGN) shares, but tentative about paying the going market price of $330.03/share, might benefit from considering selling puts among the alternative strategies at their disposal..